Robert Nelsen

Co-Founder at Vir Biotechnology, Inc.

Robert Nelsen

Robert Nelsen

Co-Founder at Vir Biotechnology, Inc.

Overview
Career Highlights

Vir Biotechnology, Inc.
ARCH Venture Partners
Risk and Return

RelSci Relationships

3158

Number of Boards

67

Birthday

1963

Age

58

Number of Awards

1

Contact Data
Trying to get in touch with Robert Nelsen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Robert Nelsen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at ARCH Venture Partners LP

Relationship likelihood: Strong

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Co-Founder & Chairman at Castlight Health, Inc.

Relationship likelihood: Strong

Managing Director at ARCH Venture Partners

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Co-Founder at Mindstrong Health

Relationship likelihood: Strong

Co-Founder & President at Unity Biotechnology, Inc.

Relationship likelihood: Strong

Co-Founder at ARCH Venture Partners

Relationship likelihood: Strong

Co-Founder at ARCH Venture Partners

Relationship likelihood: Strong

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Paths to Robert Nelsen
Potential Connections via
Relationship Science
You
Robert Nelsen
Co-Founder at Vir Biotechnology, Inc.
Education
MBA
Class of 1987

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

BS in Economics & Biology
Class of 1985

University of Puget Sound is an independent, predominantly residential, undergraduate liberal arts college with selected graduate programs building effectively on a liberal arts foundation. The university, as a community of learning, maintains a strong commitment to teaching excellence, scholarly engagement, and fruitful student-faculty interaction. The mission of the university is to develop in its students capacities for critical analysis, aesthetic appreciation, sound judgment, and apt expression that will sustain a lifetime of intellectual curiosity, active inquiry, and reasoned independence. A Puget Sound education, both academic and cocurricular, encourages a rich knowledge of self and others; an appreciation of commonality and difference; the full, open, and civil discussion of ideas; thoughtful moral discourse; and the integration of learning, preparing the university's graduates to meet the highest tests of democratic citizenship. Such an education seeks to liberate each person's fullest intellectual and human potential to assist in the unfolding of creative and useful lives.

Career History
Co-Founder
2016 - Current

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Co-Founder
1986 - Current

ARCH Venture Partners focuses on seed and early-stage investments in start-up technology companies, with a particular interest in the life sciences, the physical sciences and information technology. Their life sciences investments focus on biotechnology, pharmaceuticals, medical instrumentation and informatics. Their physical sciences investments focus on companies that are pioneering technology with a range of commercial applications in chemicals/materials, electronics/instrumentation and medical instrumentation industries. The firm's focus within the information technology sector includes electronics/hardware, information, infrastructure/software and commerce. ARCH Venture Partners invests primarily in companies located in the southwestern, Midwestern, eastern seaboard and northwestern sections of the US. The firm exits most of their investments through IPOs or private sales.

Founder
Current

Risk and Return, a for-profit early-stage Venture Fund. They accelerate new technologies that de-risk high-risk public service.

Boards & Committees
Director
Prior - 2006

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Director
Prior

Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA.

Director
Prior

R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $100K
2019

The Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA.

$10K - $100K
2018

The Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA.

$2,500 - $10K
2010

The Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA.

Political Donations
$2,800
2019

Representative from Washington's 6th Congressional District

$1,000
2019

Representative from Washington's 9th Congressional District

$10K
2019

Representative from Washington's 5th Congressional District

Transactions
Details Hidden

Madison Dearborn Partners LLC purchases Ikaria, Inc. from Venrock Associates, ARCH Venture Partners, New Mountain Capital LLC, 5AM Venture Management LLC

Investments
Details Hidden

Gali Health, Inc. consumer-focused health technology company. It involves in consumer-powered healthcare by crowdsourcing personal health data and medically-validated insights. Its product Health Assistant, which helps in personalized health management. The company was founded by Ilya Kupershmidt and is headquartered in San Francisco, CA.

Details Hidden

Pioneer Square Labs, Inc. provides studio technology services. Its companies created include LumaTax, Ad Lightning, and JetClosing. The company was founded by Greg Gottesman, Mike Galgon, Benjamin Gilbert, and Geoffrey R. Entress in 2015 and is headquartered in Seattle, WA.

Details Hidden

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Rank #73
2008
Forbes Magazine - The Midas List
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert Nelsen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert Nelsen's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert Nelsen.